{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T07:51:41Z","timestamp":1721116301300},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00108-023-01470-9","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T10:02:41Z","timestamp":1674813761000},"page":"152-163","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Myositissyndrome"],"prefix":"10.1007","volume":"64","author":[{"given":"Stylianos","family":"Tomaras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Feist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,27]]},"reference":[{"key":"1470_CR1","volume-title":"Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","author":"H Wiendl","year":"2022","unstructured":"Wiendl\u00a0H, Schmidt\u00a0J et al (2022) Myositissyndrome, S2k-Leitlinie. In: Deutsche Gesellschaft f\u00fcr Neurologie (Hrsg) Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie (www.dgn.org\/leitlinien)"},{"issue":"1","key":"1470_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","volume":"7","author":"IE Lundberg","year":"2021","unstructured":"Lundberg\u00a0IE, Fujimoto\u00a0M, Vencovsky\u00a0J, Aggarwal\u00a0R, Holmqvist\u00a0M, Christopher-Stine\u00a0L, Mammen\u00a0AL, Miller\u00a0FW (2021) Idiopathic inflammatory myopathies. Nat Rev Dis Primers 7(1):86. https:\/\/doi.org\/10.1038\/s41572-021-00321-x","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"1470_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/art.33379","volume":"64","author":"E Trallero-Aragu\u00e1s","year":"2012","unstructured":"Trallero-Aragu\u00e1s\u00a0E, Rodrigo-Pend\u00e1s\u00a0J, Selva-O\u2019Callaghan\u00a0A, Mart\u00ednez-G\u00f3mez\u00a0X, Bosch\u00a0X, Labrador-Horrillo\u00a0M, Grau-Junyent\u00a0JM, Vilardell-Tarr\u00e9s\u00a0M (2012) Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a\u00a0systematic review and meta-analysis. Arthritis Rheum 64(2):523\u2013532. https:\/\/doi.org\/10.1002\/art.33379","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1470_CR4","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/bor.0000000000000329","volume":"28","author":"M Fujimoto","year":"2016","unstructured":"Fujimoto\u00a0M, Watanabe\u00a0R, Ishitsuka\u00a0Y, Okiyama\u00a0N (2016) Recent advances in dermatomyositis-specific autoantibodies. Curr Opin Rheumatol 28(6):636\u2013644. https:\/\/doi.org\/10.1097\/bor.0000000000000329","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"1470_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.nmd.2020.02.003","volume":"30","author":"J Day","year":"2020","unstructured":"Day\u00a0J, Otto\u00a0S, Cash\u00a0K, Limaye\u00a0V (2020) Clinical and histological features of immune-mediated necrotising myopathy: A multi-centre South Australian cohort study. Neuromuscul Disord 30(3):186\u2013199. https:\/\/doi.org\/10.1016\/j.nmd.2020.02.003","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"1470_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11926-018-0732-6","volume":"20","author":"I Pinal-Fernandez","year":"2018","unstructured":"Pinal-Fernandez\u00a0I, Casal-Dominguez\u00a0M, Mammen\u00a0AL (2018) Immune-mediated necrotizing myopathy. Curr Rheumatol Rep 20(4):21. https:\/\/doi.org\/10.1007\/s11926-018-0732-6","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"1470_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12016-016-8528-9","volume":"52","author":"L Cavagna","year":"2017","unstructured":"Cavagna\u00a0L, Nuno\u00a0L, Scire\u00a0CA, Govoni\u00a0M, Longo\u00a0FJ, Franceschini\u00a0F, Neri\u00a0R, Castaneda\u00a0S, Sifuentes Giraldo\u00a0WA, Caporali\u00a0R, Iannone\u00a0F, Fusaro\u00a0E, Paolazzi\u00a0G, Pellerito\u00a0R, Schwarting\u00a0A, Saketkoo\u00a0LA, Ortego-Centeno\u00a0N, Quartuccio\u00a0L, Bartoloni\u00a0E, Specker\u00a0C, Pina Murcia\u00a0T, La Corte\u00a0R, Furini\u00a0F, Foschi\u00a0V, Bachiller Corral\u00a0J, Airo\u00a0P, Cavazzana\u00a0I, Martinez-Barrio\u00a0J, Hinojosa\u00a0M, Giannini\u00a0M, Barsotti\u00a0S, Menke\u00a0J, Triantafyllias\u00a0K, Vitetta\u00a0R, Russo\u00a0A, Bogliolo\u00a0L, Bajocchi\u00a0G, Bravi\u00a0E, Barausse\u00a0G, Bortolotti\u00a0R, Selmi\u00a0C, Parisi\u00a0S, Salaffi\u00a0F, Montecucco\u00a0C, Gonzalez-Gay\u00a0MA (2017) Serum Jo\u20111 autoantibody and isolated arthritis in the antisynthetase syndrome: Review of the literature and report of the experience of AENEAS collaborative group. Clin Rev Allergy Immunol 52(1):71\u201380. https:\/\/doi.org\/10.1007\/s12016-016-8528-9","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"1470_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/annrheumdis-2017-211868","volume":"77","author":"JB Lilleker","year":"2018","unstructured":"Lilleker\u00a0JB, Vencovsky\u00a0J, Wang\u00a0G, Wedderburn\u00a0LR, Diederichsen\u00a0LP, Schmidt\u00a0J, Oakley\u00a0P, Benveniste\u00a0O, Danieli\u00a0MG, Danko\u00a0K, Thuy\u00a0NTP, Vazquez-Del Mercado\u00a0M, Andersson\u00a0H, De Paepe\u00a0B, deBleecker\u00a0JL, Maurer\u00a0B, McCann\u00a0LJ, Pipitone\u00a0N, McHugh\u00a0N, Betteridge\u00a0ZE, New\u00a0P, Cooper\u00a0RG, Ollier\u00a0WE, Lamb\u00a0JA, Krogh\u00a0NS, Lundberg\u00a0IE, Chinoy\u00a0H (2018) The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis 77(1):30\u201339. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211868","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1470_CR9","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1212\/wnl.0000000000000642","volume":"83","author":"TE Lloyd","year":"2014","unstructured":"Lloyd\u00a0TE, Mammen\u00a0AL, Amato\u00a0AA, Weiss\u00a0MD, Needham\u00a0M, Greenberg\u00a0SA (2014) Evaluation and construction of diagnostic criteria for inclusion body myositis. Neurology 83(5):426\u2013433. https:\/\/doi.org\/10.1212\/wnl.0000000000000642","journal-title":"Neurology"},{"issue":"04","key":"1470_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1055\/a-1383-5737","volume":"46","author":"S Tomaras","year":"2021","unstructured":"Tomaras\u00a0S, Kekow\u00a0J, Feist\u00a0E (2021) Idiopathische inflammatorische Myopathien: Aktuelles zu Diagnose und Klassifikation. Akt Rheumatol 46(04):361\u2013372","journal-title":"Akt Rheumatol"},{"issue":"12","key":"1470_CR11","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41584-020-00515-9","volume":"16","author":"Y Allenbach","year":"2020","unstructured":"Allenbach\u00a0Y, Benveniste\u00a0O, Stenzel\u00a0W, Boyer\u00a0O (2020) Immune-mediated necrotizing myopathy: Clinical features and pathogenesis. Nat Rev Rheumatol 16(12):689\u2013701. https:\/\/doi.org\/10.1038\/s41584-020-00515-9","journal-title":"Nat Rev Rheumatol"},{"issue":"20","key":"1470_CR12","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1212\/wnl.0000000000003337","volume":"87","author":"A Olthoff","year":"2016","unstructured":"Olthoff\u00a0A, Carstens\u00a0PO, Zhang\u00a0S, von Fintel\u00a0E, Friede\u00a0T, Lotz\u00a0J, Frahm\u00a0J, Schmidt\u00a0J (2016) Evaluation of dysphagia by novel real-time MRI. Neurology 87(20):2132\u20132138. https:\/\/doi.org\/10.1212\/wnl.0000000000003337","journal-title":"Neurology"},{"issue":"3","key":"1470_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3899\/jrheum.180355","volume":"46","author":"M Sebastiani","year":"2019","unstructured":"Sebastiani\u00a0M, Triantafyllias\u00a0K, Manfredi\u00a0A, Gonz\u00e1lez-Gay\u00a0MA, Palmou-Fontana\u00a0N, Cassone\u00a0G, Drott\u00a0U, Delbr\u00fcck\u00a0C, Rojas-Serrano\u00a0J, Bertolazzi\u00a0C, Nu\u00f1o\u00a0L, Giannini\u00a0M, Iannone\u00a0F, Vicente\u00a0EF, Casta\u00f1eda\u00a0S, Selva-O\u2019Callaghan\u00a0A, Trallero Araguas\u00a0E, Emmi\u00a0G, Iuliano\u00a0A, Bauhammer\u00a0J, Miehle\u00a0N, Parisi\u00a0S, Cavagna\u00a0L, Codullo\u00a0V, Montecucco\u00a0C, Lopez-Longo\u00a0FJ, Mart\u00ednez-Barrio\u00a0J, Nieto-Gonz\u00e1lez\u00a0JC, Vichi\u00a0S, Confalonieri\u00a0M, Tomietto\u00a0P, Bergner\u00a0R, Sulli\u00a0A, Bonella\u00a0F, Furini\u00a0F, Scir\u00e8\u00a0CA, Bortoluzzi\u00a0A, Specker\u00a0C, Barsotti\u00a0S, Neri\u00a0R, Mosca\u00a0M, Caproni\u00a0M, Weinmann-Menke\u00a0J, Schwarting\u00a0A, Smith\u00a0V, Cutolo\u00a0M (2019) Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a\u00a0multicenter international study. J\u00a0Rheumatol 46(3):279\u2013284. https:\/\/doi.org\/10.3899\/jrheum.180355","journal-title":"J Rheumatol"},{"issue":"6","key":"1470_CR14","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1093\/rheumatology\/keab166","volume":"60","author":"AGS Oldroyd","year":"2021","unstructured":"Oldroyd\u00a0AGS, Allard\u00a0AB, Callen\u00a0JP, Chinoy\u00a0H, Chung\u00a0L, Fiorentino\u00a0D, George\u00a0MD, Gordon\u00a0P, Kolstad\u00a0K, Kurtzman\u00a0DJB, Machado\u00a0PM, McHugh\u00a0NJ, Postolova\u00a0A, Selva-O\u2019Callaghan\u00a0A, Schmidt\u00a0J, Tansley\u00a0S, Vleugels\u00a0RA, Werth\u00a0VP, Aggarwal\u00a0R (2021) A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies. Rheumatology (Oxford) 60(6):2615\u20132628. https:\/\/doi.org\/10.1093\/rheumatology\/keab166","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1470_CR15","doi-asserted-by":"publisher","first-page":"366","DOI":"10.55563\/clinexprheumatol\/21xrzf","volume":"40","author":"I Marago","year":"2022","unstructured":"Marago\u00a0I, Lilleker\u00a0JB, Chinoy\u00a0H (2022) The perils of myositis mimickers with illustrative case reports. Clin Exp Rheumatol 40(2):366\u2013372. https:\/\/doi.org\/10.55563\/clinexprheumatol\/21xrzf","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"1470_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00108-021-01059-0","volume":"62","author":"U Kassner","year":"2021","unstructured":"Kassner\u00a0U, Grunwald\u00a0S, Spira\u00a0D, Buchmann\u00a0N, Bobbert\u00a0T, Gazzerro\u00a0E, Hollstein\u00a0T, Spuler\u00a0S, Steinhagen-Thiessen\u00a0E (2021) Diagnostics and treatment of statin-associated muscle symptoms. Internist (Berl) 62(8):827\u2013840. https:\/\/doi.org\/10.1007\/s00108-021-01059-0","journal-title":"Internist (Berl)"},{"issue":"2","key":"1470_CR17","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/art.37754","volume":"65","author":"CV Oddis","year":"2013","unstructured":"Oddis\u00a0CV, Reed\u00a0AM, Aggarwal\u00a0R, Rider\u00a0LG, Ascherman\u00a0DP, Levesque\u00a0MC, Barohn\u00a0RJ, Feldman\u00a0BM, Harris-Love\u00a0MO, Koontz\u00a0DC, Fertig\u00a0N, Kelley\u00a0SS, Pryber\u00a0SL, Miller\u00a0FW, Rockette\u00a0HE (2013) Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a\u00a0randomized, placebo-phase trial. Arthritis Rheum 65(2):314\u2013324. https:\/\/doi.org\/10.1002\/art.37754","journal-title":"Arthritis Rheum"},{"issue":"18","key":"1470_CR18","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","volume":"381","author":"KR Flaherty","year":"2019","unstructured":"Flaherty\u00a0KR, Wells\u00a0AU, Cottin\u00a0V, Devaraj\u00a0A, Walsh\u00a0SLF, Inoue\u00a0Y, Richeldi\u00a0L, Kolb\u00a0M, Tetzlaff\u00a0K, Stowasser\u00a0S, Coeck\u00a0C, Clerisme-Beaty\u00a0E, Rosenstock\u00a0B, Quaresma\u00a0M, Haeufel\u00a0T, Goeldner\u00a0RG, Schlenker-Herceg\u00a0R, Brown\u00a0KK (2019) Nintedanib in progressive fibrosing interstitial lung diseases. N\u00a0Engl J Med 381(18):1718\u20131727. https:\/\/doi.org\/10.1056\/NEJMoa1908681","journal-title":"N Engl J Med"},{"issue":"1","key":"1470_CR19","doi-asserted-by":"publisher","first-page":"e23677","DOI":"10.1097\/md.0000000000023677","volume":"100","author":"R Aggarwal","year":"2021","unstructured":"Aggarwal\u00a0R, Charles-Schoeman\u00a0C, Schessl\u00a0J, Dimachkie\u00a0MM, Beckmann\u00a0I, Levine\u00a0T (2021) Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10\u202f% in patients with dermatomyositis (\u201eProDERM Study\u201c). Medicine (Baltimore) 100(1):e23677. https:\/\/doi.org\/10.1097\/md.0000000000023677","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1470_CR20","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1016\/S2665-9913(20)30280-0.hal-03180889","volume":"3","author":"O Benveniste","year":"2021","unstructured":"Benveniste\u00a0O, Hogrel\u00a0J\u2011Y, Belin\u00a0L, Annoussamy\u00a0M, Bachasson\u00a0D et al (2021) Sirolimus for treatment of patients with inclusion body myositis: a\u00a0randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial. Lancet Rheumatol 3(1):e40\u2013e48. https:\/\/doi.org\/10.1016\/S2665-9913(20)30280-0.hal-03180889","journal-title":"Lancet Rheumatol"},{"issue":"10","key":"1470_CR21","doi-asserted-by":"publisher","first-page":"102897","DOI":"10.1016\/j.autrev.2021.102897","volume":"20","author":"RG Misse","year":"2021","unstructured":"Misse\u00a0RG, Borges\u00a0IBP, Dos Santos\u00a0AM, Gupta\u00a0L, Shinjo\u00a0SK (2021) Effect of exercise training on fatigue and pain in patients with systemic autoimmune myopathies: A systematic review. Autoimmun Rev 20(10):102897. https:\/\/doi.org\/10.1016\/j.autrev.2021.102897","journal-title":"Autoimmun Rev"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-023-01470-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-023-01470-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-023-01470-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T08:05:59Z","timestamp":1675325159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-023-01470-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,27]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1470"],"URL":"https:\/\/doi.org\/10.1007\/s00108-023-01470-9","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,27]]},"assertion":[{"value":"2 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>S.\u00a0Tomaras<\/b>: A.\u00a0Finanzielle Interessen: S.\u00a0Tomaras gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Oberarzt, Leiter Schwerpunktzentrum Osteologie, Helios Fachklinik f\u00fcr Rheumatologie Vogelsang-Gommern. <b>E.\u00a0Feist<\/b>: A.\u00a0Finanzielle Interessen: Vortragshonorare oder Kostenerstattung als passiv Teilnehmender: AbbVie, AstraZeneca, Galapagos, Janssen, Lilly, Medac, Novartis, Pfizer, Roche\/Chugai, Sanofi, Sobi, UCB Honorar f\u00fcr Referentent\u00e4tigkeit.\u00a0\u2013 Bezahlte Beratungsleistungen, interne Schulungsvortr\u00e4ge, Gehaltsbezug o.\u202f\u00c4.: AbbVie, Galapagos, Janssen, Lilly, Novartis, Sanofi, Sobi, UCB Honorar als Berater.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Chefarzt Fachklinik f\u00fcr Rheumatologie | Vorstandsmitglied im Berufsverband Deutscher Rheumatologen (BDRh).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}